Genprex Competitors and Similar CompaniesClear all

Genprex's competitors and similar companies include Oragenics, NexImmune and Bluebird Bio.
Genprex
Genprex
Genprex is a gene therapy company developing treatments for cancer and diabetes.
Oragenics
Oragenics
Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis.
NexImmune
NexImmune
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Founding Date
Founding Date
2009
Founding Date
1996
Founding Date
2011
Founding Date
1992
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
West Lake Hills, US HQ
Austin, US
Locations
Tampa, US HQ
Locations
Gaithersburg, US HQ
Locations
Somerville, US HQ
Employees
Employees
2865% increase
Employees
717% increase
Employees
5032% decrease
Employees
32338% decrease
Valuation ($)
Valuation ($)
5.4 m
Valuation ($)
13.6 m
Valuation ($)
4.8 m
Valuation ($)
192.1 m
Twitter followers
Twitter followers
2.1 k
Twitter followers
44
Twitter followers
76
Twitter followers
10.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
87.5%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$37.7k (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$3.6m (FY, 2022)
Net income
Net income
($30.9m) (FY, 2023)
Net income
($20.7m) (FY, 2023)
Net income
($32.3m) (FY, 2023)
Net income
($266.6m) (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 9.9m
Total funding raised
$ 33.8m
Total funding raised
$ 409m
For sources of this data, please see the company profile

View Company Profiles

Oragenics
HQ
Tampa, US
Employees
7↑ 17% increase

Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis.

View company
NexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease

NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.

View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company